You must log in to view this page.

BioCryst Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: BCRX
Share price (3/3/26): $8.69
Market cap (3/3/26): $2.179 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Prospectus supplement

Details of business combination or exchange offer – amended

Business combination disclosure

Details of business combination or exchange offer

Business combination disclosure

Ownership Filter

Stonehouse Jon P

News Filter

Reports Full Year 2025 Financial Results and Provides Business Update

Change in Directors, Officers or Compensation

Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema

Announces Preliminary Full Year 2025 ORLADEYO® (Berotralstat) Net Revenue of $601 Million (+37 Percent Y-O-Y), Beating Prior Guidance Range

Material Disclosure

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Letter from the SEC